GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Un Audited Financials Results For Quarter & Half Year Ended 30Th September 2024

GlaxoSmithKline Pharmaceuticals Ltd.

NSE: GLAXO | BSE: 500660 | ISIN: INE159A01016 | Industry: Pharmaceuticals
| Mid-range Performer

2662.9000 -9.50 (-0.36%)

NSE Sep 29, 2025 15:40 PM

38.62% Gain from 52W Low

Volume: 89,831

GlaxoSmithKline Pharmaceuticals Ltd.

29 Oct 2024, 03:44PM

2662.90

-0.36%

Result

GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Un Audited Financials Results For Quarter & Half Year Ended …

BSE India

outcome of meeting

More from GlaxoSmithKline Pharmaceuticals Ltd.

Recommended

Market trades higher, Reliance Power to sell stake in five Indonesian coal entities for $12 mn

Trendlyne Marketwatch | 29 Sep 2025, 03:31PM

The new H1B fee: Who will it hurt the most?

The Baseline | 26 Sep 2025

Five Interesting Stocks Today - September 26, 2025

The Baseline | 26 Sep 2025